4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

Autor: Cardoso, F, Senkus, E., Costa, A, Papadopoulos, E, Aapro, M, André, F, Harbeck, N, Aguilar Lopez, B, Barrios, CH, Bergh, J, Prat, A, Boers-Doets, CB, Cardoso, MJ, Carey, LA, Cortés, J, Curigliano, G, Diéras, V, Saghir NS, EL, Eniu, A, Fallowfield, L, Francis, PA, Gelmon, K, Johnston, SRD, Kaufman, B, Koppikar, S, Krop, IE, Mayer, M, Nakigudde, G, Offersen, BV, Ohno, S, Pagani, O, Paluch-Shimon, S, Penault-Llorca, F, Prat, A., Rugo, HS, Sledge, GW, Spence, D, Thomssen, C, Vorobiof, DA, Xu, B., Norton, L, Winer, EP

Publikováno v: Annals of Oncology
Annals of Oncology, Elsevier, 2018, 29 (8), pp.1634-1657. ⟨10.1093/annonc/mdy192⟩
Ann Oncol
Cardoso, F, Senkus, E, Costa, A, Papadopoulos, E, Aapro, M, André, F, Harbeck, N, Aguilar Lopez, B, Barrios, C H, Bergh, J, Biganzoli, L, Boers-Doets, C B, Cardoso, M J, Carey, L A, Cortés, J, Curigliano, G, Diéras, V, El Saghir, N S, Eniu, A, Fallowfield, L, Francis, P A, Gelmon, K, Johnston, S R D, Kaufman, B, Koppikar, S, Krop, I E, Mayer, M, Nakigudde, G, Offersen, B V, Ohno, S, Pagani, O, Paluch-Shimon, S, Penault-Llorca, F, Prat, A, Rugo, H S, Sledge, G W, Spence, D, Thomssen, C, Vorobiof, D A, Xu, B, Norton, L & Winer, E P 2018, ' 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)† ', Annals of Oncology, vol. 29, no. 8, pp. 1634-1657 . https://doi.org/10.1093/annonc/mdy192

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c78e8b9ac48699004fce2b29f97e2da
https://hal.archives-ouvertes.fr/hal-01927983

A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer.

Autor: Bender BC, Schaedeli-Stark F, Koch R, Joshi A, Chu YW, Rugo H, Krop IE, Girish S, Friberg LE, Gupta M

Publikováno v: Cancer Chemotherapy & Pharmacology; Oct2012, Vol. 70 Issue 4, p591-601, 11p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.

Autor: Freedman RA, Bullitt E, Sun L, Gelman R, Harris G, Ligibel JA, Krop IE, Partridge AH, Eisenberg E, Winer EP, Lin NU, Freedman, Rachel A, Bullitt, Elizabeth, Sun, Lixian, Gelman, Rebecca, Harris, Gordon, Ligibel, Jennifer A, Krop, Ian E, Partridge, Ann H, Eisenberg, Emily

Publikováno v: Clinical Breast Cancer; Dec2011, Vol. 11 Issue 6, p376-383, 8p

Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancer.

Autor: Krop IE, Beeram M, Modi S, Jones SF, Holden SN, Yu W, Girish S, Tibbitts J, Yi JH, Sliwkowski MX, Jacobson F, Lutzker SG, Burris HA

Publikováno v: Journal of Clinical Oncology; 6/1/2010, Vol. 28 Issue 16, p2698-2704, 7p